Levosalbutamol
Levosalbutamol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target beta-2 adrenergic receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
936 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 31 | 72 | 126 | 113 | 97 | 436 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 12 | 34 | 84 | 75 | 64 | 267 |
| Obstructive lung diseases | D008173 | — | — | 5 | 26 | 65 | 49 | 46 | 189 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 6 | 24 | 71 | 48 | 35 | 183 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | 14 | 3 | 14 | 7 | 4 | 42 |
| Healthy volunteers/patients | — | — | — | 19 | 1 | — | 3 | 15 | 38 |
| Bronchiolitis | D001988 | — | — | 3 | 3 | 2 | 5 | 13 | 26 |
| Status asthmaticus | D013224 | — | — | 2 | 5 | 4 | 4 | 6 | 18 |
| Bronchial spasm | D001986 | — | — | — | 2 | 4 | 5 | 3 | 14 |
| Exercise-induced asthma | D001250 | — | J45.990 | — | — | 6 | 4 | 1 | 11 |
Show 53 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | 2 | — | 11 | 13 |
| Fibrosis | D005355 | — | — | 1 | — | 2 | — | 9 | 12 |
| Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | 2 | 3 | 2 | — | 1 | 6 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | 2 | 1 | — | 2 | 6 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | 1 | 1 | — | 4 | 5 |
| Acute lung injury | D055371 | EFO_0004610 | — | 2 | 2 | 1 | — | 1 | 5 |
| Lung injury | D055370 | — | S27.30 | — | 2 | 1 | — | 2 | 4 |
| Bronchial hyperreactivity | D016535 | — | — | — | — | 1 | — | 3 | 4 |
| Transient tachypnea of the newborn | D059245 | — | P22.1 | 2 | — | 2 | — | — | 4 |
| Tachypnea | D059246 | — | R06.82 | 2 | — | 2 | — | — | 4 |
Show 21 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cough | D003371 | — | R05 | — | 1 | — | — | 1 | 2 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | 1 | — | — | — | 2 |
| Discoid lupus erythematosus | D008179 | — | L93.0 | — | 2 | — | — | — | 2 |
| Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | — | 2 | — | — | — | 2 |
| Pulmonary edema | D011654 | EFO_1001134 | J81 | 1 | 2 | — | — | — | 2 |
| Sclerosis | D012598 | — | — | — | 1 | — | — | 1 | 2 |
| Lymphangioleiomyomatosis | D018192 | — | J84.81 | 1 | 1 | — | — | — | 1 |
| Viral bronchiolitis | D001990 | — | — | — | 1 | — | — | — | 1 |
| Brain death | D001926 | — | G93.82 | — | 1 | — | — | — | 1 |
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | — | 1 | — | — | — | 1 |
Show 3 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | — | — | 14 | — | — | — | — | 14 |
| Covid-19 | D000086382 | — | U07.1 | 1 | — | — | — | 4 | 5 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | — | — | — | 3 | 4 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 2 | — | — | — | 1 | 3 |
| Ciliary motility disorders | D002925 | EFO_0003900 | — | 1 | — | — | — | 2 | 3 |
| Syndrome | D013577 | — | — | 2 | — | — | — | — | 2 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | — | — | — | 1 | 2 |
| Dyskinesias | D020820 | — | G24 | 1 | — | — | — | 1 | 2 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | — | — | — | — | 1 |
| Cicatrix | D002921 | — | L90.5 | 1 | — | — | — | — | 1 |
Show 4 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Smoking | D012907 | EFO_0004318 | — | — | — | — | — | 4 | 4 |
| Airway remodeling | D056151 | — | — | — | — | — | — | 3 | 3 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 3 | 3 |
| Respiratory signs and symptoms | D012818 | — | — | — | — | — | — | 2 | 2 |
| Muscular dystrophies | D009136 | EFO_0000757 | G71.0 | — | — | — | — | 2 | 2 |
| Child mortality | D046688 | — | — | — | — | — | — | 2 | 2 |
| Noninvasive ventilation | D063087 | — | — | — | — | — | — | 2 | 2 |
| Artificial respiration | D012121 | — | — | — | — | — | — | 1 | 1 |
| Pulmonary atelectasis | D001261 | — | J98.1 | — | — | — | — | 1 | 1 |
| Acute kidney injury | D058186 | — | N17 | — | — | — | — | 1 | 1 |
Show 71 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Levosalbutamol |
| INN | levosalbutamol |
| Description | (R)-salbutamol is an albuterol. |
| Classification | Small molecule |
| Drug class | anti-inflammatory agents (salicylic acid derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1 |
Identifiers
| PDB | — |
| CAS-ID | 34391-04-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1002 |
| ChEBI ID | 8746 |
| PubChem CID | 123600 |
| DrugBank | DB13139 |
| UNII ID | EDN2NBH5SS (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Levosalbutamol
+
Levalbuterol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,342 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use